Could not agree more. Lots at stake here ranging from FDA career positions to BP investments to who knows in D.C.(swamp). Dr.M, Dr. G, Ms. Woodcock and many others have an opportunity to lead FDA out of the past 40 years of CNS trial failures. In fact this a kind of PROCESS CHANGE at FDA which provides new dynamics for learning and for adaptive benefits to all involved. Hope we never look back except to wonder what took so long.